SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001636050-17-000057
Filing Date
2017-11-02
Accepted
2017-11-02 16:40:48
Documents
51
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a9301710qaxovant.htm 10-Q 948952
2 EXHIBIT 10.1 a93017exhibit101.htm EX-10.1 39132
3 EXHIBIT 10.2 a93017exhibit102.htm EX-10.2 49137
4 EXHIBIT 31.1 a93017exhibit311.htm EX-31.1 10095
5 EXHIBIT 31.2 a93017exhibit312.htm EX-31.2 10028
6 EXHIBIT 32.1 a93017exhibit321.htm EX-32.1 6326
7 EXHIBIT 32.2 a93017exhibit322.htm EX-32.2 6308
  Complete submission text file 0001636050-17-000057.txt   2971929

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT axon-20170930.xml EX-101.INS 289825
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axon-20170930.xsd EX-101.SCH 25946
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axon-20170930_cal.xml EX-101.CAL 43673
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axon-20170930_def.xml EX-101.DEF 111618
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axon-20170930_lab.xml EX-101.LAB 348348
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axon-20170930_pre.xml EX-101.PRE 194428
Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS
Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS 441-295-5950
Axovant Sciences Ltd. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37418 | Film No.: 171173043
SIC: 2834 Pharmaceutical Preparations